Company History

Xanapath, LLC has been formed to bring hyper-spectral imaging technology to the market, benefitting therapeutics through improved and advanced diagnostic information. Xanapath has been formed based on cooperation between Lynntech, Inc., a technology-development company, and the University of Texas Southwestern Medical Center. The technology utilized by Xanapath was developed within the Garnering Innovation research labs at UT Southwestern and includes patented processes for generating advanced diagnostics.